Task: Answer the multiple-choice question.
Question: Which drug exhibits a 18.813% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: CCC(=O)NCCc1nc2cc(NC(=O)Nc3ccccc3)ccc2n1C
b: Cc1ccccc1NC(=S)NC(=O)CCc1ccccc1
Answer: a. CCC(=O)NCCc1nc2cc(NC(=O)Nc3ccccc3)ccc2n1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)NCCc1nc2cc(NC(=O)Nc3ccccc3)ccc2n1C
CCC(=O)NCCc1nc2cc(NC(=O)Nc3ccccc3)ccc2n1C
N-[2-[1-methyl-5-(phenylcarbamoylamino)benzimidazol-2-yl]ethyl]propanamide